Global Oncology Medication Market Size, Status and Forecast 2021-2027

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Oncology Medication Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
  • 1.2.2 Chemotherapy Medication
  • 1.2.3 Targeted Therapy Medication
  • 1.2.4 Immunotherapy Medication
  • 1.2.5 Hormonal Therapy Medication
  • 1.2.6 Others
• 1.3 Market by Application
  • 1.3.1 Global Oncology Medication Market Share by Application: 2016 VS 2021 VS 2027
  • 1.3.2 Blood Cancer
  • 1.3.3 Breast Cancer
  • 1.3.4 Gastrointestinal Cancer
  • 1.3.5 Prostate Cancer
  • 1.3.6 Respiratory or Lung Cancer
  • 1.3.7 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Oncology Medication Market Perspective (2016-2027)
• 2.2 Oncology Medication Growth Trends by Regions
  • 2.2.1 Oncology Medication Market Size by Regions: 2016 VS 2021 VS 2027
  • 2.2.2 Oncology Medication Historic Market Share by Regions (2016-2021)
  • 2.2.3 Oncology Medication Forecasted Market Size by Regions (2022-2027)
• 2.3 Oncology Medication Industry Dynamic
  • 2.3.1 Oncology Medication Market Trends
  • 2.3.2 Oncology Medication Market Drivers
  • 2.3.3 Oncology Medication Market Challenges
  • 2.3.4 Oncology Medication Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Oncology Medication Players by Revenue
  • 3.1.1 Global Top Oncology Medication Players by Revenue (2016-2021)
  • 3.1.2 Global Oncology Medication Revenue Market Share by Players (2016-2021)
• 3.2 Global Oncology Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Oncology Medication Revenue
• 3.4 Global Oncology Medication Market Concentration Ratio
  • 3.4.1 Global Oncology Medication Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Oncology Medication Revenue in 2020
• 3.5 Oncology Medication Key Players Head office and Area Served
• 3.6 Key Players Oncology Medication Product Solution and Service
• 3.7 Date of Enter into Oncology Medication Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Oncology Medication Breakdown Data by Type

• 4.1 Global Oncology Medication Historic Market Size by Type (2016-2021)
• 4.2 Global Oncology Medication Forecasted Market Size by Type (2022-2027)

5 Oncology Medication Breakdown Data by Application

• 5.1 Global Oncology Medication Historic Market Size by Application (2016-2021)
• 5.2 Global Oncology Medication Forecasted Market Size by Application (2022-2027)

6 North America

• 6.1 North America Oncology Medication Market Size (2016-2027)
• 6.2 North America Oncology Medication Market Size by Type
  • 6.2.1 North America Oncology Medication Market Size by Type (2016-2021)
  • 6.2.2 North America Oncology Medication Market Size by Type (2022-2027)
  • 6.2.3 North America Oncology Medication Market Size by Type (2016-2027)
• 6.3 North America Oncology Medication Market Size by Application
  • 6.3.1 North America Oncology Medication Market Size by Application (2016-2021)
  • 6.3.2 North America Oncology Medication Market Size by Application (2022-2027)
  • 6.3.3 North America Oncology Medication Market Size by Application (2016-2027)
• 6.4 North America Oncology Medication Market Size by Country
  • 6.4.1 North America Oncology Medication Market Size by Country (2016-2021)
  • 6.4.2 North America Oncology Medication Market Size by Country (2022-2027)
  • 6.4.3 United States
  • 6.4.3 Canada

7 Europe

• 7.1 Europe Oncology Medication Market Size (2016-2027)
• 7.2 Europe Oncology Medication Market Size by Type
  • 7.2.1 Europe Oncology Medication Market Size by Type (2016-2021)
  • 7.2.2 Europe Oncology Medication Market Size by Type (2022-2027)
  • 7.2.3 Europe Oncology Medication Market Size by Type (2016-2027)
• 7.3 Europe Oncology Medication Market Size by Application
  • 7.3.1 Europe Oncology Medication Market Size by Application (2016-2021)
  • 7.3.2 Europe Oncology Medication Market Size by Application (2022-2027)
  • 7.3.3 Europe Oncology Medication Market Size by Application (2016-2027)
• 7.4 Europe Oncology Medication Market Size by Country
  • 7.4.1 Europe Oncology Medication Market Size by Country (2016-2021)
  • 7.4.2 Europe Oncology Medication Market Size by Country (2022-2027)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic

8 Asia-Pacific

• 8.1 Asia-Pacific Oncology Medication Market Size (2016-2027)
• 8.2 Asia-Pacific Oncology Medication Market Size by Type
  • 8.2.1 Asia-Pacific Oncology Medication Market Size by Type (2016-2021)
  • 8.2.2 Asia-Pacific Oncology Medication Market Size by Type (2022-2027)
  • 8.2.3 Asia-Pacific Oncology Medication Market Size by Type (2016-2027)
• 8.3 Asia-Pacific Oncology Medication Market Size by Application
  • 8.3.1 Asia-Pacific Oncology Medication Market Size by Application (2016-2021)
  • 8.3.2 Asia-Pacific Oncology Medication Market Size by Application (2022-2027)
  • 8.3.3 Asia-Pacific Oncology Medication Market Size by Application (2016-2027)
• 8.4 Asia-Pacific Oncology Medication Market Size by Region
  • 8.4.1 Asia-Pacific Oncology Medication Market Size by Region (2016-2021)
  • 8.4.2 Asia-Pacific Oncology Medication Market Size by Region (2022-2027)
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 Southeast Asia
  • 8.4.7 India
  • 8.4.8 Australia

9 Latin America

• 9.1 Latin America Oncology Medication Market Size (2016-2027)
• 9.2 Latin America Oncology Medication Market Size by Type
  • 9.2.1 Latin America Oncology Medication Market Size by Type (2016-2021)
  • 9.2.2 Latin America Oncology Medication Market Size by Type (2022-2027)
  • 9.2.3 Latin America Oncology Medication Market Size by Type (2016-2027)
• 9.3 Latin America Oncology Medication Market Size by Application
  • 9.3.1 Latin America Oncology Medication Market Size by Application (2016-2021)
  • 9.3.2 Latin America Oncology Medication Market Size by Application (2022-2027)
  • 9.3.3 Latin America Oncology Medication Market Size by Application (2016-2027)
• 9.4 Latin America Oncology Medication Market Size by Country
  • 9.4.1 Latin America Oncology Medication Market Size by Country (2016-2021)
  • 9.4.2 Latin America Oncology Medication Market Size by Country (2022-2027)
  • 9.4.3 Mexico
  • 9.4.4 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Oncology Medication Market Size (2016-2027)
• 10.2 Middle East & Africa Oncology Medication Market Size by Type
  • 10.2.1 Middle East & Africa Oncology Medication Market Size by Type (2016-2021)
  • 10.2.2 Middle East & Africa Oncology Medication Market Size by Type (2022-2027)
  • 10.2.3 Middle East & Africa Oncology Medication Market Size by Type (2016-2027)
• 10.3 Middle East & Africa Oncology Medication Market Size by Application
  • 10.3.1 Middle East & Africa Oncology Medication Market Size by Application (2016-2021)
  • 10.3.2 Middle East & Africa Oncology Medication Market Size by Application (2022-2027)
  • 10.3.3 Middle East & Africa Oncology Medication Market Size by Application (2016-2027)
• 10.4 Middle East & Africa Oncology Medication Market Size by Country
  • 10.4.1 Middle East & Africa Oncology Medication Market Size by Country (2016-2021)
  • 10.4.2 Middle East & Africa Oncology Medication Market Size by Country (2022-2027)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 UAE

11 Key Players Profiles

• 11.1 Roche
  • 11.1.1 Roche Company Details
  • 11.1.2 Roche Business Overview
  • 11.1.3 Roche Oncology Medication Introduction
  • 11.1.4 Roche Revenue in Oncology Medication Business (2016-2021)
  • 11.1.5 Roche Recent Development
• 11.2 Celgene
  • 11.2.1 Celgene Company Details
  • 11.2.2 Celgene Business Overview
  • 11.2.3 Celgene Oncology Medication Introduction
  • 11.2.4 Celgene Revenue in Oncology Medication Business (2016-2021)
  • 11.2.5 Celgene Recent Development
• 11.3 Novartis
  • 11.3.1 Novartis Company Details
  • 11.3.2 Novartis Business Overview
  • 11.3.3 Novartis Oncology Medication Introduction
  • 11.3.4 Novartis Revenue in Oncology Medication Business (2016-2021)
  • 11.3.5 Novartis Recent Development
• 11.4 Bristol-Myers Squibb
  • 11.4.1 Bristol-Myers Squibb Company Details
  • 11.4.2 Bristol-Myers Squibb Business Overview
  • 11.4.3 Bristol-Myers Squibb Oncology Medication Introduction
  • 11.4.4 Bristol-Myers Squibb Revenue in Oncology Medication Business (2016-2021)
  • 11.4.5 Bristol-Myers Squibb Recent Development
• 11.5 Johnson & Johnson
  • 11.5.1 Johnson & Johnson Company Details
  • 11.5.2 Johnson & Johnson Business Overview
  • 11.5.3 Johnson & Johnson Oncology Medication Introduction
  • 11.5.4 Johnson & Johnson Revenue in Oncology Medication Business (2016-2021)
  • 11.5.5 Johnson & Johnson Recent Development
• 11.6 Merck & Co.
  • 11.6.1 Merck & Co. Company Details
  • 11.6.2 Merck & Co. Business Overview
  • 11.6.3 Merck & Co. Oncology Medication Introduction
  • 11.6.4 Merck & Co. Revenue in Oncology Medication Business (2016-2021)
  • 11.6.5 Merck & Co. Recent Development
• 11.7 AstraZeneca
  • 11.7.1 AstraZeneca Company Details
  • 11.7.2 AstraZeneca Business Overview
  • 11.7.3 AstraZeneca Oncology Medication Introduction
  • 11.7.4 AstraZeneca Revenue in Oncology Medication Business (2016-2021)
  • 11.7.5 AstraZeneca Recent Development
• 11.8 Pfizer
  • 11.8.1 Pfizer Company Details
  • 11.8.2 Pfizer Business Overview
  • 11.8.3 Pfizer Oncology Medication Introduction
  • 11.8.4 Pfizer Revenue in Oncology Medication Business (2016-2021)
  • 11.8.5 Pfizer Recent Development
• 11.9 Amgen
  • 11.9.1 Amgen Company Details
  • 11.9.2 Amgen Business Overview
  • 11.9.3 Amgen Oncology Medication Introduction
  • 11.9.4 Amgen Revenue in Oncology Medication Business (2016-2021)
  • 11.9.5 Amgen Recent Development
• 11.10 Takeda
  • 11.10.1 Takeda Company Details
  • 11.10.2 Takeda Business Overview
  • 11.10.3 Takeda Oncology Medication Introduction
  • 11.10.4 Takeda Revenue in Oncology Medication Business (2016-2021)
  • 11.10.5 Takeda Recent Development
• 11.11 Astellas
  • 11.11.1 Astellas Company Details
  • 11.11.2 Astellas Business Overview
  • 11.11.3 Astellas Oncology Medication Introduction
  • 11.11.4 Astellas Revenue in Oncology Medication Business (2016-2021)
  • 11.11.5 Astellas Recent Development
• 11.12 Ipsen
  • 11.12.1 Ipsen Company Details
  • 11.12.2 Ipsen Business Overview
  • 11.12.3 Ipsen Oncology Medication Introduction
  • 11.12.4 Ipsen Revenue in Oncology Medication Business (2016-2021)
  • 11.12.5 Ipsen Recent Development
• 11.13 Sanofi
  • 11.13.1 Sanofi Company Details
  • 11.13.2 Sanofi Business Overview
  • 11.13.3 Sanofi Oncology Medication Introduction
  • 11.13.4 Sanofi Revenue in Oncology Medication Business (2016-2021)
  • 11.13.5 Sanofi Recent Development
• 11.14 Bayer
  • 11.14.1 Bayer Company Details
  • 11.14.2 Bayer Business Overview
  • 11.14.3 Bayer Oncology Medication Introduction
  • 11.14.4 Bayer Revenue in Oncology Medication Business (2016-2021)
  • 11.14.5 Bayer Recent Development
• 11.15 Biogen Idec
  • 11.15.1 Biogen Idec Company Details
  • 11.15.2 Biogen Idec Business Overview
  • 11.15.3 Biogen Idec Oncology Medication Introduction
  • 11.15.4 Biogen Idec Revenue in Oncology Medication Business (2016-2021)
  • 11.15.5 Biogen Idec Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer